Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
Identifieur interne : 000298 ( Main/Exploration ); précédent : 000297; suivant : 000299Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
Auteurs : I. Obando [Espagne] ; M S Camacho-Lovillo ; A. Porras ; M A Gandía-González ; A. Molinos ; I. Vazquez-Barba ; B. Morillo-Gutierrez ; O W Neth ; D. TarragoSource :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1469-0691 ] ; 2012.
Descripteurs français
- KwdFr :
- Empyème (microbiologie), Empyème (épidémiologie), Enfant (MeSH), Enfant d'âge préscolaire (MeSH), Espagne (épidémiologie), Femelle (MeSH), Humains (MeSH), Incidence (MeSH), Infections à pneumocoques (microbiologie), Infections à pneumocoques (épidémiologie), Mâle (MeSH), Prévalence (MeSH), Réaction de polymérisation en chaine en temps réel (MeSH), Réaction de polymérisation en chaine multiplex (MeSH), Streptococcus pneumoniae (classification), Streptococcus pneumoniae (génétique), Streptococcus pneumoniae (isolement et purification), Sérotypie (MeSH), Typage moléculaire (MeSH), Vaccins antipneumococciques (immunologie), Études prospectives (MeSH).
- MESH :
- génétique : Streptococcus pneumoniae.
- immunologie : Streptococcus pneumoniae, Vaccins antipneumococciques.
- isolement et purification : Streptococcus pneumoniae.
- microbiologie : Empyème, Infections à pneumocoques.
- épidémiologie : Empyème, Espagne, Infections à pneumocoques.
- Enfant, Enfant d'âge préscolaire, Femelle, Humains, Incidence, Mâle, Prévalence, Réaction de polymérisation en chaine en temps réel, Réaction de polymérisation en chaine multiplex, Sérotypie, Typage moléculaire, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Child (MeSH), Child, Preschool (MeSH), Empyema (epidemiology), Empyema (microbiology), Female (MeSH), Humans (MeSH), Incidence (MeSH), Male (MeSH), Molecular Typing (MeSH), Multiplex Polymerase Chain Reaction (MeSH), Pneumococcal Infections (epidemiology), Pneumococcal Infections (microbiology), Pneumococcal Vaccines (immunology), Prevalence (MeSH), Prospective Studies (MeSH), Real-Time Polymerase Chain Reaction (MeSH), Serotyping (MeSH), Spain (epidemiology), Streptococcus pneumoniae (classification), Streptococcus pneumoniae (genetics), Streptococcus pneumoniae (isolation & purification).
- MESH :
- chemical , immunology : Pneumococcal Vaccines.
- geographic , epidemiology : Spain.
- classification : Streptococcus pneumoniae.
- epidemiology : Empyema, Pneumococcal Infections.
- genetics : Streptococcus pneumoniae.
- isolation & purification : Streptococcus pneumoniae.
- microbiology : Empyema, Pneumococcal Infections.
- Child, Child, Preschool, Female, Humans, Incidence, Male, Molecular Typing, Multiplex Polymerase Chain Reaction, Prevalence, Prospective Studies, Real-Time Polymerase Chain Reaction, Serotyping.
Abstract
The epidemiology and microbiological characteristics of paediatric parapneumonic empyema (PPE) before the introduction of the new generation of conjugate pneumococcal vaccines (10-valent and 13-valent) are described. All patients <14 years old admitted to a tertiary paediatric hospital with a diagnosis of PPE were prospectively enrolled from January 2005 to December 2009. Pneumococcal serotyping of culture-negative pleural fluid samples was performed using a multiplex real-time PCR assay. Overall, 219 patients had PPE. Incidence rates for PPE remained stable during the study period with a not significant increase in 2009 compared with 2005 (p 0.13), and were temporally associated with higher circulation of pandemic influenza A H1N1 during the last quarter in our population (p 0.001). Pneumococci were detected in 72% of culture-positive and 79% of culture-negative samples. Serotypes were determined in 104 PPE cases. Serotype 1 was the most prevalent serotype identified (42%) followed by serotypes 7F (20%), 3 (16%), 19A (8%) and 5 (7%). Serotype distribution remained similar during all time periods. Pneumococcal serotype 1 remained the most common cause of PPE during the 5-year study. The new generation of pneumococcal conjugate vaccines offers potential serotype coverage of 73% (10-valent) and 99% (13-valent) in the population studied suffering from PPE. Continuous epidemiological and molecular studies are paramount to monitor the impact of pneumococcal vaccines on the epidemiology of PPE.
DOI: 10.1111/j.1469-0691.2011.03632.x
PubMed: 21910779
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.</title><author><name sortKey="Obando, I" sort="Obando, I" uniqKey="Obando I" first="I" last="Obando">I. Obando</name><affiliation wicri:level="1"><nlm:affiliation>Department of Paediatric Infectious Diseases and Immunology, Hospital Infantil Universitario Virgen del Rocío, Sevilla, Spain. IOSANTAELLA@telefonica.net</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Paediatric Infectious Diseases and Immunology, Hospital Infantil Universitario Virgen del Rocío, Sevilla</wicri:regionArea><wicri:noRegion>Sevilla</wicri:noRegion></affiliation></author><author><name sortKey="Camacho Lovillo, M S" sort="Camacho Lovillo, M S" uniqKey="Camacho Lovillo M" first="M S" last="Camacho-Lovillo">M S Camacho-Lovillo</name></author><author><name sortKey="Porras, A" sort="Porras, A" uniqKey="Porras A" first="A" last="Porras">A. Porras</name></author><author><name sortKey="Gandia Gonzalez, M A" sort="Gandia Gonzalez, M A" uniqKey="Gandia Gonzalez M" first="M A" last="Gandía-González">M A Gandía-González</name></author><author><name sortKey="Molinos, A" sort="Molinos, A" uniqKey="Molinos A" first="A" last="Molinos">A. Molinos</name></author><author><name sortKey="Vazquez Barba, I" sort="Vazquez Barba, I" uniqKey="Vazquez Barba I" first="I" last="Vazquez-Barba">I. Vazquez-Barba</name></author><author><name sortKey="Morillo Gutierrez, B" sort="Morillo Gutierrez, B" uniqKey="Morillo Gutierrez B" first="B" last="Morillo-Gutierrez">B. Morillo-Gutierrez</name></author><author><name sortKey="Neth, O W" sort="Neth, O W" uniqKey="Neth O" first="O W" last="Neth">O W Neth</name></author><author><name sortKey="Tarrago, D" sort="Tarrago, D" uniqKey="Tarrago D" first="D" last="Tarrago">D. Tarrago</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:21910779</idno><idno type="pmid">21910779</idno><idno type="doi">10.1111/j.1469-0691.2011.03632.x</idno><idno type="wicri:Area/Main/Corpus">00344</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00344</idno><idno type="wicri:Area/Main/Curation">000344</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000344</idno><idno type="wicri:Area/Main/Exploration">000344</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.</title><author><name sortKey="Obando, I" sort="Obando, I" uniqKey="Obando I" first="I" last="Obando">I. Obando</name><affiliation wicri:level="1"><nlm:affiliation>Department of Paediatric Infectious Diseases and Immunology, Hospital Infantil Universitario Virgen del Rocío, Sevilla, Spain. IOSANTAELLA@telefonica.net</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Paediatric Infectious Diseases and Immunology, Hospital Infantil Universitario Virgen del Rocío, Sevilla</wicri:regionArea><wicri:noRegion>Sevilla</wicri:noRegion></affiliation></author><author><name sortKey="Camacho Lovillo, M S" sort="Camacho Lovillo, M S" uniqKey="Camacho Lovillo M" first="M S" last="Camacho-Lovillo">M S Camacho-Lovillo</name></author><author><name sortKey="Porras, A" sort="Porras, A" uniqKey="Porras A" first="A" last="Porras">A. Porras</name></author><author><name sortKey="Gandia Gonzalez, M A" sort="Gandia Gonzalez, M A" uniqKey="Gandia Gonzalez M" first="M A" last="Gandía-González">M A Gandía-González</name></author><author><name sortKey="Molinos, A" sort="Molinos, A" uniqKey="Molinos A" first="A" last="Molinos">A. Molinos</name></author><author><name sortKey="Vazquez Barba, I" sort="Vazquez Barba, I" uniqKey="Vazquez Barba I" first="I" last="Vazquez-Barba">I. Vazquez-Barba</name></author><author><name sortKey="Morillo Gutierrez, B" sort="Morillo Gutierrez, B" uniqKey="Morillo Gutierrez B" first="B" last="Morillo-Gutierrez">B. Morillo-Gutierrez</name></author><author><name sortKey="Neth, O W" sort="Neth, O W" uniqKey="Neth O" first="O W" last="Neth">O W Neth</name></author><author><name sortKey="Tarrago, D" sort="Tarrago, D" uniqKey="Tarrago D" first="D" last="Tarrago">D. Tarrago</name></author></analytic><series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title><idno type="eISSN">1469-0691</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Child (MeSH)</term><term>Child, Preschool (MeSH)</term><term>Empyema (epidemiology)</term><term>Empyema (microbiology)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Male (MeSH)</term><term>Molecular Typing (MeSH)</term><term>Multiplex Polymerase Chain Reaction (MeSH)</term><term>Pneumococcal Infections (epidemiology)</term><term>Pneumococcal Infections (microbiology)</term><term>Pneumococcal Vaccines (immunology)</term><term>Prevalence (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Real-Time Polymerase Chain Reaction (MeSH)</term><term>Serotyping (MeSH)</term><term>Spain (epidemiology)</term><term>Streptococcus pneumoniae (classification)</term><term>Streptococcus pneumoniae (genetics)</term><term>Streptococcus pneumoniae (isolation & purification)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Empyème (microbiologie)</term><term>Empyème (épidémiologie)</term><term>Enfant (MeSH)</term><term>Enfant d'âge préscolaire (MeSH)</term><term>Espagne (épidémiologie)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Infections à pneumocoques (microbiologie)</term><term>Infections à pneumocoques (épidémiologie)</term><term>Mâle (MeSH)</term><term>Prévalence (MeSH)</term><term>Réaction de polymérisation en chaine en temps réel (MeSH)</term><term>Réaction de polymérisation en chaine multiplex (MeSH)</term><term>Streptococcus pneumoniae (classification)</term><term>Streptococcus pneumoniae (génétique)</term><term>Streptococcus pneumoniae (isolement et purification)</term><term>Sérotypie (MeSH)</term><term>Typage moléculaire (MeSH)</term><term>Vaccins antipneumococciques (immunologie)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Pneumococcal Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Empyema</term><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Streptococcus pneumoniae</term><term>Vaccins antipneumococciques</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Empyème</term><term>Infections à pneumocoques</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Empyema</term><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Empyème</term><term>Espagne</term><term>Infections à pneumocoques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Child</term><term>Child, Preschool</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Molecular Typing</term><term>Multiplex Polymerase Chain Reaction</term><term>Prevalence</term><term>Prospective Studies</term><term>Real-Time Polymerase Chain Reaction</term><term>Serotyping</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Prévalence</term><term>Réaction de polymérisation en chaine en temps réel</term><term>Réaction de polymérisation en chaine multiplex</term><term>Sérotypie</term><term>Typage moléculaire</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The epidemiology and microbiological characteristics of paediatric parapneumonic empyema (PPE) before the introduction of the new generation of conjugate pneumococcal vaccines (10-valent and 13-valent) are described. All patients <14 years old admitted to a tertiary paediatric hospital with a diagnosis of PPE were prospectively enrolled from January 2005 to December 2009. Pneumococcal serotyping of culture-negative pleural fluid samples was performed using a multiplex real-time PCR assay. Overall, 219 patients had PPE. Incidence rates for PPE remained stable during the study period with a not significant increase in 2009 compared with 2005 (p 0.13), and were temporally associated with higher circulation of pandemic influenza A H1N1 during the last quarter in our population (p 0.001). Pneumococci were detected in 72% of culture-positive and 79% of culture-negative samples. Serotypes were determined in 104 PPE cases. Serotype 1 was the most prevalent serotype identified (42%) followed by serotypes 7F (20%), 3 (16%), 19A (8%) and 5 (7%). Serotype distribution remained similar during all time periods. Pneumococcal serotype 1 remained the most common cause of PPE during the 5-year study. The new generation of pneumococcal conjugate vaccines offers potential serotype coverage of 73% (10-valent) and 99% (13-valent) in the population studied suffering from PPE. Continuous epidemiological and molecular studies are paramount to monitor the impact of pneumococcal vaccines on the epidemiology of PPE.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21910779</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2012</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-0691</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>8</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin. Microbiol. Infect.</ISOAbbreviation></Journal><ArticleTitle>Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.</ArticleTitle><Pagination><MedlinePgn>763-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1469-0691.2011.03632.x</ELocationID><Abstract><AbstractText>The epidemiology and microbiological characteristics of paediatric parapneumonic empyema (PPE) before the introduction of the new generation of conjugate pneumococcal vaccines (10-valent and 13-valent) are described. All patients <14 years old admitted to a tertiary paediatric hospital with a diagnosis of PPE were prospectively enrolled from January 2005 to December 2009. Pneumococcal serotyping of culture-negative pleural fluid samples was performed using a multiplex real-time PCR assay. Overall, 219 patients had PPE. Incidence rates for PPE remained stable during the study period with a not significant increase in 2009 compared with 2005 (p 0.13), and were temporally associated with higher circulation of pandemic influenza A H1N1 during the last quarter in our population (p 0.001). Pneumococci were detected in 72% of culture-positive and 79% of culture-negative samples. Serotypes were determined in 104 PPE cases. Serotype 1 was the most prevalent serotype identified (42%) followed by serotypes 7F (20%), 3 (16%), 19A (8%) and 5 (7%). Serotype distribution remained similar during all time periods. Pneumococcal serotype 1 remained the most common cause of PPE during the 5-year study. The new generation of pneumococcal conjugate vaccines offers potential serotype coverage of 73% (10-valent) and 99% (13-valent) in the population studied suffering from PPE. Continuous epidemiological and molecular studies are paramount to monitor the impact of pneumococcal vaccines on the epidemiology of PPE.</AbstractText><CopyrightInformation>© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Obando</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Paediatric Infectious Diseases and Immunology, Hospital Infantil Universitario Virgen del Rocío, Sevilla, Spain. IOSANTAELLA@telefonica.net</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho-Lovillo</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Porras</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gandía-González</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Molinos</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Vazquez-Barba</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Morillo-Gutierrez</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Neth</LastName><ForeName>O W</ForeName><Initials>OW</Initials></Author><Author ValidYN="Y"><LastName>Tarrago</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004653" MajorTopicYN="N">Empyema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058889" MajorTopicYN="N">Molecular Typing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060885" MajorTopicYN="N">Multiplex Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21910779</ArticleId><ArticleId IdType="doi">10.1111/j.1469-0691.2011.03632.x</ArticleId><ArticleId IdType="pii">S1198-743X(14)63435-2</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country></list><tree><noCountry><name sortKey="Camacho Lovillo, M S" sort="Camacho Lovillo, M S" uniqKey="Camacho Lovillo M" first="M S" last="Camacho-Lovillo">M S Camacho-Lovillo</name><name sortKey="Gandia Gonzalez, M A" sort="Gandia Gonzalez, M A" uniqKey="Gandia Gonzalez M" first="M A" last="Gandía-González">M A Gandía-González</name><name sortKey="Molinos, A" sort="Molinos, A" uniqKey="Molinos A" first="A" last="Molinos">A. Molinos</name><name sortKey="Morillo Gutierrez, B" sort="Morillo Gutierrez, B" uniqKey="Morillo Gutierrez B" first="B" last="Morillo-Gutierrez">B. Morillo-Gutierrez</name><name sortKey="Neth, O W" sort="Neth, O W" uniqKey="Neth O" first="O W" last="Neth">O W Neth</name><name sortKey="Porras, A" sort="Porras, A" uniqKey="Porras A" first="A" last="Porras">A. Porras</name><name sortKey="Tarrago, D" sort="Tarrago, D" uniqKey="Tarrago D" first="D" last="Tarrago">D. Tarrago</name><name sortKey="Vazquez Barba, I" sort="Vazquez Barba, I" uniqKey="Vazquez Barba I" first="I" last="Vazquez-Barba">I. Vazquez-Barba</name></noCountry><country name="Espagne"><noRegion><name sortKey="Obando, I" sort="Obando, I" uniqKey="Obando I" first="I" last="Obando">I. Obando</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000298 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000298 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21910779
|texte= Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21910779" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |